Delayed panel on vaccine injury payments to meet next monthnews2025-11-26T16:44:30+00:00November 26th, 2025|Endpoints News|
FDA pushes back Ascendis’ dwarfism drug decision date by three monthsnews2025-11-26T13:57:06+00:00November 26th, 2025|Endpoints News|
Sanofi headquarters raided in broader French tax fraud investigationnews2025-11-26T11:46:20+00:00November 26th, 2025|Endpoints News|
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgANnews2025-11-26T00:52:17+00:00November 26th, 2025|Endpoints News|
CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second roundnews2025-11-25T23:09:56+00:00November 25th, 2025|Endpoints News|
Pharma faces deadline to bring IRA fight to Supreme Court as first set of negotiated prices loomsnews2025-11-25T17:32:39+00:00November 25th, 2025|Endpoints News|
FDA approves Novartis’ Itvisma for older patients with spinal muscular atrophynews2025-11-25T12:09:26+00:00November 25th, 2025|Endpoints News|
Novartis was the sole bidder in $12B deal to buy Aviditynews2025-11-25T09:00:28+00:00November 25th, 2025|Endpoints News|
UK-US drug pricing deal could come as early as this week, sources saynews2025-11-24T20:53:12+00:00November 24th, 2025|Endpoints News|
J&J’s tau-targeting antibody fails Phase 2 Alzheimer’s studynews2025-11-24T16:22:48+00:00November 24th, 2025|Endpoints News|
